Connexins protect mouse pancreatic β cells against apoptosis

Journal of Clinical Investigation

Volumn 121, Issue 12, 2011, Pages 4870-4879

  Klee, Philippe ^a   Allagnat, Florent ^b   Pontes, Helena ^a   Cederroth, Manon ^a   Charollais, Anne ^a   Caille, Dorothée ^a   Britan, Aurore ^a   Haefliger, Jacques Antoine ^b   Meda, Paolo ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 36; CYTOTOXIC AGENT; GAMMA INTERFERON; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ALLOXAN; ANIMALS; APOPTOSIS; CELL COMMUNICATION; CELLULAR MICROENVIRONMENT; CONNEXINS; DIABETES MELLITUS, EXPERIMENTAL; GAP JUNCTIONS; GENE DOSAGE; INSULIN; INTERFERON-GAMMA; INTERLEUKIN-1BETA; ISLETS OF LANGERHANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NITRIC OXIDE; PROMOTER REGIONS, GENETIC; RATS; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; STREPTOZOCIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84055199884     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI40509     Document Type: Article

References (42)

1. Bavamian S, et al. Islet-cell-to-cell communication as basis for normal insulin secretion. Diabetes Obes Metab. 2007;9 suppl 2:118-132. (Pubitemid 47543134)
2. Serre-Beinier V, et al. Cx36 preferentially connects beta-cells within pancreatic islets. Diabetes. 2000;49(5):727-734. (Pubitemid 30339987)
3. Serre-Beinier V, et al. Cx36 makes channels coupling human pancreatic beta-cells, and correlates with insulin expression. Hum Mol Genet. 2009; 18(3):428-439.
4. Theis M, et al. Replacement by a lacZ reporter gene assigns mouse connexin36, 45 and 43 to distinct cell types in pancreatic islets. Exp Cell Res. 2004; 294(1):18-29. (Pubitemid 38229776)
5. Harris AL, Locke D, eds. Connexin: A Guide. New York, New York, USA: Springer; 2009.
6. Calabrese A, et al. Connexin 36 controls synchronization of Ca2+ oscillations and insulin secretion in MIN6 cells. Diabetes. 2003;52(2):417-424. (Pubitemid 36173198)
7. Ravier MA, et al. Loss of connexin36 channels alters beta-cell coupling, islet synchronization of glucoseinduced Ca2+ and insulin oscillations, and basal insulin release. Diabetes. 2005;54(6):1798-1807. (Pubitemid 40770770)
8. Speier S, Gjinovci A, Charollais A, Meda P, Rupnik M. Cx36-mediated coupling reduces beta-cell heterogeneity, confines the stimulating glucose concentration range, and affects insulin release kinetics. Diabetes. 2007;56(4):1078-1086. (Pubitemid 46525063)
9. Wellershaus K, et al. A new conditional mouse mutant reveals specific expression and functions of connexin36 in neurons and pancreatic beta-cells. Exp Cell Res. 2008;314(5):997-1012.
10. Le Gurun S, et al. Connexin-36 contributes to control function of insulin-producing cells. J Biol Chem. 2003;278(39):37690-37697. (Pubitemid 37175293)
11. Lenzen S. The mechanisms of alloxan- and streptozotocin- induced diabetes. Diabetologia. 2008; 51(2):216-226.
12. Charollais A, et al. Junctional communication of pancreatic beta cells contributes to the control of insulin secretion and glucose tolerance. J Clin Invest. 2000;106(2):235-243. (Pubitemid 30483127)
13. Güldenagel M, et al. Visual transmission deficits in mice with targeted disruption of the gap junction gene connexin36. J Neurosci. 2001;21(16):6036-6044. (Pubitemid 32737737)
14. Klee P, et al. Connexin implication in the control of the murine beta-cell mass. Pediatr Res. 2011;70(2):142-147.
15. Cnop M, Welsh N, Jonas J, Jorns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes. 2005;54 suppl 2:S97-S107. (Pubitemid 43343337)
16. Eizirik DL, Mandrup-Poulsen T. A choice of death: the signal-transduction of immune-mediated betacell apoptosis. Diabetologia. 2001;44(12):2115-2133. (Pubitemid 34015464)
17. Loaiza A, Porras OH, Barros LF. Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J Neurosci. 2003;23(19):7337-7342. (Pubitemid 36999523)
18. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia. 2000;43(12):1528-1533. (Pubitemid 32734859)
19. Kim KA, Lee MS. Recent progress in research on beta-cell apoptosis by cytokines. Front Biosci. 2009;14:657-664.
20. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia. 1996;39(8):875-890. (Pubitemid 26249106)
21. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 2000;10(9):369-377. (Pubitemid 30612469)
22. Bernardi P, Rasola A. Calcium and cell death: the mitochondrial connection. Subcell Biochem. 2007;45:481-506.
23. Hoorens A, Stangé G, Pavlovic D, Pipeleers D. Distinction between interleukin-1-induced necrosis and apoptosis of islet cells. Diabetes. 2001;50(3):551-557. (Pubitemid 32195219)
24. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol. 2009;5(4):219-226.
25. Liu D, Pavlovic D, Chen MC, Flodström M, Sandler S, Eizirik DL. Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes. 2000; 49(7):1116-1122. (Pubitemid 30439084)
26. Saldeen J. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology. 2000;141(6):2003-2010. (Pubitemid 32274349)
27. Charpantier E, Cancela J, Meda P. Beta cells preferentially exchange cationic molecules via connexin 36 gap junction channels. Diabetologia. 2007;50(11):2332-2341. (Pubitemid 47512410)
28. Harris AL. Emerging issues of connexin channels: biophysics fills the gap. Q Rev Biophys. 2001;34(3):325-472. (Pubitemid 34123306)
29. Rossini AA, Appel MC, Williams RM, Like AA. Genetic influence of the streptozotocininduced insulitis and hyperglycemia. Diabetes. 1977;26(10):916-920. (Pubitemid 8205499)
30. Mathews CE, Leiter EH. Constitutive differences in antioxidant defense status distinguish alloxanresistant and alloxan-susceptible mice. Free Radic Biol Med. 1999;27:449-455. (Pubitemid 29395440)
31. Hosokawa M, Dolci W, Thorens B. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin. Biochem Biophys Res Commun. 2001;289(5):1114-1117. (Pubitemid 34076306)
32. Bosco D, Haefliger JA, Meda P. Connexins: key mediators of endocrine function. Physiol Rev. In press.
33. Srinivas M. Pharmacology of connexin channels. In: Harris AL, Locke D, eds. Connexins. A Guide. New York, New York, USA: Humana Press-Springer; 2009:207-224.
34. Plotkin LI, Manolagas SC, Bellido T. Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem. 2002;277(10):8648-8657. (Pubitemid 34968331)
35. Bivi N, Lezcano V, Romanello M, Bellido T, Plotkin LI. Connexin43 interacts with beta-arrestin: a pre-requisite for osteoblast survival induced by parathyroid hormone. J Cell Biochem. 2011; 112(10):2920-2930.
36. Scemes E, Bavamian S, Charollais A, Spray DC, Meda P. Lack of "hemichannel" activity in insulin-producing cells. Cell Commun Adhes. 2008;15(1):143-154.
37. Meda P, Perrelet A, Orci L. Increase of gap junctions between pancreatic B-cells during stimulation of insulin secretion. J Cell Biol. 1979;82(2):441-448. (Pubitemid 9241108)
38. Meda P, Halban P, Perrelet A, Renold AE, Orci L. Gap junction development is correlated with insulin content in the pancreatic B cell. Science. 1980;209(4460):1026-1028. (Pubitemid 10014878)
39. Xu H, Murray M, McLachlan AJ. Influence of genetic polymorphisms on the pharmacokinetics and pharmaco-dynamics of sulfonylurea drugs. Curr Drug Metab. 2009;10(6):643-658.
40. Del Guerra S, et al. Effects of exposure of human islet beta-cells to normal and high glucose levels with or without gliclazide or glibenclamide. Diabetes Metab. 2009;35(4):293-298.
41. Bavamian S. Connexin36: A Novel Therapeutic Target To Correct Beta-Cell Dysfunctions? [thesis]. Geneva, Switzerland: University of Geneva; Sc 4151, 2009.
42. Michon L, et al. Involvement of gap junctional communication in secretion. Biochim Biophys Acta. 2005;1719(1-2):82-101. (Pubitemid 41785638)